Dry Granulation Excipients Market Analysis

  • Report ID: 5979
  • Published Date: Dec 01, 2025
  • Report Format: PDF, PPT

Dry Granulation Excipients Market Segmentation:

Formulation Segment Analysis

The oral formulations segment in the dry granulation excipients market is estimated to gain the largest revenue share of about ~42% in the year 2035. The segment growth can be attributed to its wide usage and efficacy against various diseases. For instance, 361.3 million medications are administered or prescribed annually, and 76.2% of consultations involve drug therapy. This high usage of oral formulations can be attributed to their convenience, ease of administration, and patent compliance. Dry granulation excipients play a vital role in formulating these dosage forms, as a result driving growth in the oral formulation segment.

Product Segment Analysis

The lubricants and glidants in the dry granulation excipients market are estimated to gain a significant share of about ~18% in the year 2035. The segment growth can be attributed to the high utilization in manufacturing of oral solid dosage forms which are the most popular form of dosage. Lubricants and glidants play a crucial role in dry granulation by improving the flow properties of powders and reducing friction between particles and equipment surfaces. This leads to smoother processing, reduced equipment wear, and increased manufacturing efficiency, driving the demand for lubricants and glidants in the dry granulation excipient market.

Our in-depth analysis of the dry granulation excipient market includes the following segments:

     Products

  • Disintegrants & Lubricants
  • Organic Chemicals
  • Oleochemicals
  • Carbohydrates
  • Petrochemicals
  • Others

    Formulation

  • Oral formulation
  • Tablets
  • Capsules

     End-User

  • Pharmaceutical Companies
  • Chemical Industries
  • Research Institution

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of dry granulation excipients is estimated at USD 14.8 billion.

The global dry granulation excipients market size was around USD 13.82 billion in 2025 and is likely to expand at a CAGR of more than 7.9%, surpassing USD 29.56 billion revenue by 2035.

By 2035, the Asia Pacific region is expected to capture a 34% share in the dry granulation excipients market, underpinned by the swift expansion of its pharmaceutical industry.

Key players in the market include DFE Pharma, Gattefosse, BASF, MultiMedia Pharma Sciences, LLC, Colorcon, GEA Group, Aktiengesellschaft, Ashland Inc., Roquette Freres.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos